Follow
Karlheinz Peter
Karlheinz Peter
Baker Heart & Diabetes Institute
Verified email at baker.edu.au
Title
Cited by
Cited by
Year
Engineering multifunctional capsules through the assembly of metal–phenolic networks
J Guo, Y Ping, H Ejima, K Alt, M Meissner, JJ Richardson, Y Yan, K Peter, ...
Angewandte Chemie International Edition 53 (22), 5546-5551, 2014
8912014
Integrin cytoplasmic domains mediate inside-out signal transduction
TE O'Toole, Y Katagiri, RJ Faull, K Peter, R Tamura, V Quaranta, ...
The Journal of cell biology 124 (6), 1047-1059, 1994
8701994
The emerging threat of (micro) thrombosis in COVID-19 and its therapeutic implications
JD McFadyen, H Stevens, K Peter
Circulation research 127 (4), 571-587, 2020
6162020
Microparticles: major transport vehicles for distinct microRNAs in circulation
P Diehl, A Fricke, L Sander, J Stamm, N Bassler, N Htun, M Ziemann, ...
Cardiovascular research 93 (4), 633-644, 2012
5992012
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease
DM Good, P Zürbig, A Argiles, HW Bauer, G Behrens, JJ Coon, M Dakna, ...
Molecular & cellular proteomics 9 (11), 2424-2437, 2010
5542010
Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P …
K Peter, P Nawroth, C Conradt, T Nordt, T Weiss, M Boehme, A Wunsch, ...
Arteriosclerosis, thrombosis, and vascular biology 17 (3), 505-512, 1997
4121997
Clinical proteomics: a need to define the field and to begin to set adequate standards
H Mischak, R Apweiler, RE Banks, M Conaway, J Coon, A Dominiczak, ...
PROTEOMICS–Clinical Applications 1 (2), 148-156, 2007
3602007
Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities
LA Bienvenu, J Noonan, X Wang, K Peter
Cardiovascular research 116 (14), 2197-2206, 2020
3292020
Recommendations for biomarker identification and qualification in clinical proteomics
H Mischak, G Allmaier, R Apweiler, T Attwood, M Baumann, A Benigni, ...
Science translational medicine 2 (46), 46ps42-46ps42, 2010
3272010
Induction of Fibrinogen Binding and Platelet Aggregation as a Potential Intrinsic Property of Various Glycoprotein IIb/IIIa (IIbβ3) Inhibitors
K Peter, M Schwarz, J Ylänne, B Kohler, M Moser, T Nordt, P Salbach, ...
Blood, The Journal of the American Society of Hematology 92 (9), 3240-3249, 1998
3211998
New oral anticoagulant drugs in cardiovascular disease
I Ahrens, GYH Lip, K Peter
Thrombosis and haemostasis 104 (07), 49-60, 2010
3202010
Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques
SU Eisenhardt, J Habersberger, A Murphy, YC Chen, KJ Woollard, ...
Circulation research 105 (2), 128-137, 2009
3122009
CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1
A Zirlik, C Maier, N Gerdes, L MacFarlane, J Soosairajah, U Bavendiek, ...
Circulation 115 (12), 1571-1580, 2007
2832007
Current and future antiplatelet therapies: emphasis on preserving haemostasis
JD McFadyen, M Schaff, K Peter
Nature Reviews Cardiology 15 (3), 181-191, 2018
2672018
Urinary proteomic biomarkers in coronary artery disease
LU Zimmerli, E Schiffer, P Zürbig, DM Good, M Kellmann, L Mouls, AR Pitt, ...
Molecular & cellular proteomics 7 (2), 290-298, 2008
2622008
Obligatory role for B cells in the development of angiotensin II–dependent hypertension
CT Chan, CG Sobey, M Lieu, D Ferens, MM Kett, H Diep, HA Kim, ...
Hypertension 66 (5), 1023-1033, 2015
2382015
Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets
M Schwarz, G Meade, P Stoll, J Ylanne, N Bassler, YC Chen, ...
Circulation research 99 (1), 25-33, 2006
2372006
Dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation: in vivo proof of a powerful proinflammatory mechanism and a new anti …
JR Thiele, J Habersberger, D Braig, Y Schmidt, K Goerendt, V Maurer, ...
Circulation 130 (1), 35-50, 2014
2312014
Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension
SM Krishnan, YH Ling, BM Huuskes, DM Ferens, N Saini, CT Chan, ...
Cardiovascular Research 115 (4), 776-787, 2019
2232019
C-reactive protein: how conformational changes influence inflammatory properties
SU Eisenhardt, JR Thiele, H Bannasch, GB Stark, K Peter
Cell cycle 8 (23), 3885-3892, 2009
2142009
The system can't perform the operation now. Try again later.
Articles 1–20